▲ SURGE

HCW Biologics Inc.

+262.0%
HCWBNASDAQHealthcare2026-05-15
1.22
Close
0.337
Prev Close
+262.02%
Change
11.1x
Vol Ratio

Why It Surged

No related news available.

Related News

HC Wainwright & Co. Maintains Buy on SAB Biotherapeutics, Raises Price Target to $10 - SAB Biotherapeutic
Benzinga2026-05-12
Harvard Bioscience shares are trading higher after the company reported preliminary Q4 results, issued FY26 outlook and outlined its long-term strategic focus areas. - Harvard Bioscience (NASDAQ:HBIO)
Benzinga2026-02-10
HC Wainwright & Co. Reiterates Buy on Q32 Bio, Maintains $13 Price Target - Q32 Bio (NASDAQ:QTTB)
Benzinga2026-05-05
HLB생명과학, 인체조직 이식재 사업 확대
inews242026-03-24
Biohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures
Tipranks2026-05-06

Technical Analysis

Signals
BB Upper BreakOverboughtMACD BullishAbove SMA20
Key Indicators
83.00RSI (14)
0.43SMA 20
0.04Bollinger Lower
0.81Bollinger Upper
0.43Bollinger Mid
0.05MACD
-0.01MACD Signal
0.05MACD Hist
View CompanyBack to Surge Stocks
HCW Biologics Inc. Surged +262.0% on 2026-05-15 — Analysis | Alpha Lenz